Consultation: CRG actions July 2026

We now seek comments on the actions proposed by the GMMMG Clinical Reference Group at their May 2026 meeting.

All comments will be reviewed but please do not expect a personal reply as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.

Please note

1. So your comment can be fully actioned, your contact information may be shared with the authors of the consultation document, or with members of GMMMG or its subgroups.
2. This consultation will run for six weeks and closes at 5pm on Friday 11^th September 2026.

Name *

Email *

Email

Confirm Email

Your job title *

Your employer *

Locality

Are you responding on behalf of an organisation or as an individual? *

• On behalf of an organisation or organisational leader
• As an individual

Please specify who you are responding for, including job title and organisation as appropriate *

1a. Can your locality provide access to the medicines with positive NICE TAs included in the attached consultation document?

• Yes
• No (please provide detail below)

1b. Please provide detail on the barriers to providing access and how they might be addressed.

2a. Do you agree with the other proposed actions in the consultation document?

• Yes
• No (please provide detail below)

2b. Please specify which decision(s) are not appropriate, and explain why.

Do you have any additional comments?

Submit